Company: ZDAN
Filing Date: 2025-02-18
Form Type: DRS/A
Source: 0001683168-25-001085
Chunk: 8

Company: Zerolimit Technology Holding Co. Ltd.
Filing Date: 2025-02-18
Form: DRS/A
Chunk 8
---
                                             |     |     | Per            
 Ordinary Share |     |     | Total                         
 Without Over-Allotment Option |     |     | Total                      
 With Over-Allotment Option |
| Initial public offering price               |     | US$ | –              |     | US$ | –                             |     | US$ | –                          |
| Underwriting discounts (1)                  |     | US$ | –              |     | US$ | –                             |     | US$ | –                          |
| Proceeds to our Company before expenses (2) |     | US$ | –              |     | US$ | –                             |     | US$ | –                          |

| (1) | Represents underwriting discounts equal to seven percent (7.00%) per                                                                   
 Ordinary Share. See “Underwriting” in this prospectus for more information regarding the Underwriter                                   
 compensation and offering expenses.                                                                                                    |
| (2) | In addition to the underwriting discounts listed above, we have agreed                                                                 
 to issue, upon closing of this offering, warrants to Prime Number Capital LLC, the Underwriter, exercisable during the four-year       
 and six-month period after the commencement of sale of securities in this offering, entitling the Underwriter to purchase five percent 
 (5%) of the total number of Ordinary Shares sold in this offering (including any Ordinary Share sold as a result of the exercise       
 of the Underwriter’s over-allotment option) at a per share price equal to 125% of the public offering price (the “Underwriter’s        
 Warrants”). The registration statement of which this prospectus is a part also covers the Underwriter’s Warrants and                   
 the Ordinary Shares issuable upon the exercise thereof. See “Underwriting” for additional information                                  
 regarding total underwriting compensation.                                                                                             |

We have granted the Underwriter
an option for a period of [45] days after the closing of this offering to purchase up to fifteen percent (15%) of the total number of
Ordinary Shares to be offered by us pursuant to this offering (excluding Ordinary Shares subject to this option), solely for the purpose
of covering over-allotments, if any, at the public offering price less the underwriting discounts. If the Underwriter exercises the option
in full, the total underwriting discounts payable will be $[·], based on an assumed public
offering price of $[·] per Ordinary Share, which is the midpoint of the estimated initial
public offering